Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 52

Sort by

Sort Order Select

Journal Articles

Fibrinogen Activates FAK to Promote the Colorectal Adenocarcinoma Growth

Balkrishan Sharma, PhD, Duaa Mureb, BS, Sumit Murab, PhD, Leah A. Rosenfeldt, BS, Brenton J Francisco, MD, Alexander A Boucher, MD, Rachel Cantrell, BS, Jacob Mast, Matthew J. Flick, PhD, Patrick W Whitlock, MD, Joseph S. Palumbo, MD

Blood (2019) 134 (Supplement_1): 1111.

https://doi.org/10.1182/blood-2019-130497

Published: 2019

Journal Articles

Transformation from Indolent Primary Cutaneous Marginal Zone Lymphoma to Aggressive Primary Cutaneous Diffuse Large B-Cell Lymphoma: A Rare Case and Review of the Literature

Emily Harris, Ariel Sindel, DO, Ian McConnell, William Clark, MDMS, Alden Chesney, MD, Victor Yazbeck, MD

Blood (2019) 134 (Supplement_1): 5266.

https://doi.org/10.1182/blood-2019-130921

Published: 2019

Journal Articles

Central Nervous System Relapse in Patients with Peripheral T-Cell Lymphoma

Hyehyun Jeong, MD, Jung Yong Hong, Dok Hyun Yoon, Shin Kim, Jung Sun Park, Sang Wook Lee, Chan Sik Park, MD, Jin-Sook Ryu, Jooryung Huh, Cheolwon Suh

Blood (2018) 132 (Supplement 1): 5346.

https://doi.org/10.1182/blood-2018-99-119980

Published: 2018

Journal Articles

Aberrant Regional DNA Hypermethylation As a Preventive and Therapeutic Target for Adult T-Cell Leukemia-Lymphoma

Tatsuro Watanabe, PhD, Hiroshi Ureshino, MD, Yuki Kurahashi, Yuki Fukuda-Kurahashi, Satoshi Yamashita, PhD, Toshikazu Ushijima, MD PhD, Seiji Okada, MD PhD, Eisaburo Sueoka, MD PhD, Shinya Kimura, MD PhD

Blood (2018) 132 (Supplement 1): 4175.

https://doi.org/10.1182/blood-2018-99-117536

Published: 2018

Journal Articles

Hedgehog Pathway Inhibitor for Treatment of Steroid-Refractory Sclerodermatous Chronic Graft-Versus-Host Disease (GVHD)

Ridhi Gupta, MD, Abdulwahab Albabtain, MD, Sally Arai, MD, Bernice Kwong, MD, Wen-Kai Weng, MD PhD

Blood (2018) 132 (Supplement 1): 3409.

https://doi.org/10.1182/blood-2018-99-113915

Published: 2018

Journal Articles

FINAL Results of an Phase, Multicenter, Randomied, Controlled OPEN LEVEL Trial: Decitabine Therapy in Patients with Myelodysplastic Syndromes

Zonghong Shao, MD, Hui Liu, Hao Jiang, Hongyan Tong, PhD, Ruixiang Xiang, Linhua Yang, Hongguo Zhao, MD, Jian Ouyang, MD, Hai Bai, Hui Sun, Li Hou, Ming Jiang, Zeng Yun, MD PhD, Zhuogang Liu, Aibin Liang, MD PhD, Yinghua Xie, Kang Yu, MD, Zhimin Zhai, MD, Li Liu

Blood (2018) 132 (Supplement 1): 3865.

https://doi.org/10.1182/blood-2018-99-116041

Published: 2018

Journal Articles

Inhibition of the Integrin αVβ3 Improves the Immune and Anti-Lymphoma Effects of Bexarotene in Cutaneous T-Cell Lymphoma (CTCL)

Maria Florencia Cayrol, Maria Mercedes Debernardi, Maria Victoria Revuelta, PhD, Alejandra Paulazo, Maria Nieves Calvo Vidal, PhD, Jude M Phillip, DPhil, Helena Sterle, Maria Celeste Diaz Flaque, Graciela Cremaschi, Leandro Cerchietti, MD

Blood (2017) 130 (Supplement 1): 732.

https://doi.org/10.1182/blood.V130.Suppl_1.732.732

Published: 2017

Journal Articles

Rituximab-Bendamustine in First Line Treatment of Patients with Follicular Lymphoma. Results of Prospective Multicenter Study

Nesterova Ekaterina, MD PhD, Sergey K. Kravchenko, MD PhD, Alla M. Kovrigina, MD PhD, Lubov V. Plastinina, MD PhD, Yana K. Mangasarova, MD PhD, Liliya Gorenkova, PhD, Vladimir Vorobyev, MD PhD, Dmitriy Mariin, Elena A. Baryakh, MD PhD, Yuriy Polyakov, Pervin Zeynalova, MD PhD, Elena Volodicheva, MD, Nataliya Glonina, Valeriy G. Savchenko

Blood (2017) 130 (Supplement 1): 5170.

https://doi.org/10.1182/blood.V130.Suppl_1.5170.5170

Published: 2017

Journal Articles

Novel Von Willebrand Factor (vWF) Fragment Supports Subcutaneous Administration of Factor VIII: Pharmacokinetic Data from Hemophilia A Mouse Model

Nadine Vollack, PhD, Sonja Werwitzke, MD PhD, Barbara A Solecka-Witulska, PhD, Christoph Kannicht, PhD, Andreas Tiede, MD

Blood (2017) 130 (Supplement 1): 4877.

https://doi.org/10.1182/blood.V130.Suppl_1.4877.4877

Published: 2017

Journal Articles

Improved Prognosis of Extranodal NK/T-Cell Lymphoma, Nasal Type (ENKL) of Nasal Origin but Not Extranasal Origin: An Analysis of NKEA Study

Blood (2017) 130 (Supplement 1): 1518.

https://doi.org/10.1182/blood.V130.Suppl_1.1518.1518

Published: 2017

Journal Articles

Use of Bortezomib-Containing Regimens in the Frontline Treatment of Patients with Plasmablastic Lymphoma: A Multicenter Retrospective Analysis

Thomas Guerrero, MD, Michele Bibas, MD, Franco Baldini, MD, Guillaume Cartron, Kate Cwynarski, MD, Daan Dierickx, MD PhD, Frederick Lansigan, MD, Yevgeniy A Linnik, MD, Renzo Mogollon, MD, Jose Tomas Navarro, MD PhD, Slavisa Ninkovic, MBBS FRACP FRCPA, Adam J Olszewski, MD, John L. Reagan, MD, Emmanuelle Tchernonog, MD, Thomas Tousseyn, MD PhD, Jorge J. Castillo, MD

Blood (2017) 130 (Supplement 1): 1580.

https://doi.org/10.1182/blood.V130.Suppl_1.1580.1580

Published: 2017

Journal Articles

Lacrimal gland and extensive subcutaneous tissue involvement by mantle cell lymphoma

Iman Khodarahmi, Nasrin Ghesani

Blood (2017) 130 (9): 1174.

https://doi.org/10.1182/blood-2017-05-786343

Published: 2017

Journal Articles

30 Day Readmissions in Patients with Deep Vein Thrombosis in United States

Keyur Patel, MBBS, Kathan Dilipbhai Mehta, MBBS, MPH, Smit Patel, MBBS, MPH, Smith Giri, MBBS, Hong Wang, PhD, Roy E. Smith, MD, Rahul Atul Parikh, MD PhD

Blood (2016) 128 (22): 4727.

https://doi.org/10.1182/blood.V128.22.4727.4727

Published: 2016

Journal Articles

Dose-Adjusted (DA) - EPOCH-R with High-Dose Methotrexate for Newly Diagnosed CD5-Positive Diffuse Large B-Cell Lymphoma (CD5+ DLBCL): Interim Results from a Phase II Study

Blood (2016) 128 (22): 3029.

https://doi.org/10.1182/blood.V128.22.3029.3029

Published: 2016

Journal Articles

A Constitutively-Active ABL Family Kinase, TEL-ARG, Induces Lethal Mastocytosis through Sensitizing Hematopoietic Stem/Progenitor Cells to IL-3

Asumi Yokota, PhD, Hideyo Hirai, MD PhD, Tsukimi Shoji, Taira Maekawa, MD PhD, Keiko Okuda, MD PhD

Blood (2015) 126 (23): 2828.

https://doi.org/10.1182/blood.V126.23.2828.2828

Published: 2015

Journal Articles

Ixazomib, an Investigational Oral Proteasome Inhibitor (PI), in Combination with Lenalidomide and Dexamethasone (IRd), Significantly Extends Progression-Free Survival (PFS) for Patients (Pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): The Phase 3 Tourmaline-MM1 Study (NCT01564537)

Blood (2015) 126 (23): 727.

https://doi.org/10.1182/blood.V126.23.727.727

Published: 2015

Journal Articles

Clinical Features and Prognosis of CD20-Positive Peripheral T-Cell Lymphoma, Not Otherwise Specified (PTCL-NOS) in Chinese Patients: A Retrospective Single Institution Analysis

Shaoxuan Hu, Xiaohui He, MD, Yuankai Shi, MD PhD, Sheng Yang, MD, Yan Qin, MD, Jianliang Yang, MD, Mei Dong, MD, Shengyu Zhou, MD, Peng Liu, MD, Lin Gui, MD, Changgong Zhang, MD, Liqiang Zhou, MD

Blood (2015) 126 (23): 5045.

https://doi.org/10.1182/blood.V126.23.5045.5045

Published: 2015

Journal Articles

Comprehensive Biological and Molecular Characterization of a RARE Case of Cutaneous Richter Syndrome

Ramona Cassin, MD, Gianluigi Reda, MD, Sonia Fabris, BSc, Nicola Orofino, MD, Bruno Fattizzo, MD, Umberto Gianelli, MD, Antonino Neri, Pr, MD, Agostino Cortelezzi, MD

Blood (2015) 126 (23): 5281.

https://doi.org/10.1182/blood.V126.23.5281.5281

Published: 2015

Journal Articles

Genomic Characterization Of Newly Established Two Distinct Patient-Driven Multiple Myeloma Cell Lines (SNU_MM1393_BM and SNU_MM1393_SC) From a Single Patient

Youngil Koh, MD, Kwang-Sung Ahn, Ph.D., Chansu Lee, MS, Woo June Jung, BS, Hyun Jung Lee, MD, Dong Soon Lee, MD, PhD, Hyo Jung Kim, M.D., Ph.D., Hwi-Joong Yoon, MD, Ph.D., Sung-Soo Yoon, MD, PhD

Blood (2013) 122 (21): 5361.

https://doi.org/10.1182/blood.V122.21.5361.5361

Published: 2013

Journal Articles

Human Chorionic Gonadotropin Hormone Induces Indoleamine 2,3-Dioxygenase and Interleukin-10 Expression In Patients With Graft-Versus-Host-Disease

Ahmet H. Elmaagacli, MD, Markus Ditschkowski, MD, Nina-Kristin Steckel, MD, Hellmut Ottinger, MD, Uwe Hillen, MD, Rudolf Trenschel, Dietrich Beelen, MD, Michael Koldehoff, MD

Blood (2013) 122 (21): 911.

https://doi.org/10.1182/blood.V122.21.911.911

Published: 2013

NARROW

Fibrinogen Activates FAK to Promote the Colorectal Adenocarcinoma Growth

Transformation from Indolent Primary Cutaneous Marginal Zone Lymphoma to Aggressive Primary Cutaneous Diffuse Large B-Cell Lymphoma: A Rare Case and Review of the Literature

Central Nervous System Relapse in Patients with Peripheral T-Cell Lymphoma

Aberrant Regional DNA Hypermethylation As a Preventive and Therapeutic Target for Adult T-Cell Leukemia-Lymphoma

Hedgehog Pathway Inhibitor for Treatment of Steroid-Refractory Sclerodermatous Chronic Graft-Versus-Host Disease (GVHD)

FINAL Results of an Phase, Multicenter, Randomied, Controlled OPEN LEVEL Trial: Decitabine Therapy in Patients with Myelodysplastic Syndromes

Inhibition of the Integrin αVβ3 Improves the Immune and Anti-Lymphoma Effects of Bexarotene in Cutaneous T-Cell Lymphoma (CTCL)

Rituximab-Bendamustine in First Line Treatment of Patients with Follicular Lymphoma. Results of Prospective Multicenter Study

Novel Von Willebrand Factor (vWF) Fragment Supports Subcutaneous Administration of Factor VIII: Pharmacokinetic Data from Hemophilia A Mouse Model

Improved Prognosis of Extranodal NK/T-Cell Lymphoma, Nasal Type (ENKL) of Nasal Origin but Not Extranasal Origin: An Analysis of NKEA Study

Use of Bortezomib-Containing Regimens in the Frontline Treatment of Patients with Plasmablastic Lymphoma: A Multicenter Retrospective Analysis

Lacrimal gland and extensive subcutaneous tissue involvement by mantle cell lymphoma

30 Day Readmissions in Patients with Deep Vein Thrombosis in United States

Dose-Adjusted (DA) - EPOCH-R with High-Dose Methotrexate for Newly Diagnosed CD5-Positive Diffuse Large B-Cell Lymphoma (CD5+ DLBCL): Interim Results from a Phase II Study

A Constitutively-Active ABL Family Kinase, TEL-ARG, Induces Lethal Mastocytosis through Sensitizing Hematopoietic Stem/Progenitor Cells to IL-3

Ixazomib, an Investigational Oral Proteasome Inhibitor (PI), in Combination with Lenalidomide and Dexamethasone (IRd), Significantly Extends Progression-Free Survival (PFS) for Patients (Pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): The Phase 3 Tourmaline-MM1 Study (NCT01564537)

Clinical Features and Prognosis of CD20-Positive Peripheral T-Cell Lymphoma, Not Otherwise Specified (PTCL-NOS) in Chinese Patients: A Retrospective Single Institution Analysis

Comprehensive Biological and Molecular Characterization of a RARE Case of Cutaneous Richter Syndrome

Genomic Characterization Of Newly Established Two Distinct Patient-Driven Multiple Myeloma Cell Lines (SNU_MM1393_BM and SNU_MM1393_SC) From a Single Patient

Human Chorionic Gonadotropin Hormone Induces Indoleamine 2,3-Dioxygenase and Interleukin-10 Expression In Patients With Graft-Versus-Host-Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only